These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24568899)

  • 1. [Strategies to improve therapeutic efficacy in childhood acute myeloid leukemia].
    Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):108-10. PubMed ID: 24568899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.
    Luo H; Qin Y; Reu F; Ye S; Dai Y; Huang J; Wang F; Zhang D; Pan L; Zhu H; Wu Y; Niu T; Xiao Z; Zheng Y; Liu T
    J Hematol Oncol; 2016 Nov; 9(1):125. PubMed ID: 27855695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic prognostic factors in childhood acute myeloid leukemia].
    Reinhardt D; Von Neuhoff C; Sander A; Creutzig U
    Klin Padiatr; 2012 Oct; 224(6):372-6. PubMed ID: 22821298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood acute myeloid leukemia: an Indian perspective.
    Kulkarni KP; Marwaha RK
    Pediatr Hematol Oncol; 2011 May; 28(4):257-68. PubMed ID: 21214409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival in adults with acute myelogenous leukemia].
    Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T
    Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcome in pediatric AML due to augmented supportive care.
    Jastaniah W; Abrar MB; Khattab TM
    Pediatr Blood Cancer; 2012 Nov; 59(5):919-21. PubMed ID: 22619004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup.
    Büchner T; Schlenk RF; Schaich M; Döhner K; Krahl R; Krauter J; Heil G; Krug U; Sauerland MC; Heinecke A; Späth D; Kramer M; Scholl S; Berdel WE; Hiddemann W; Hoelzer D; Hehlmann R; Hasford J; Hoffmann VS; Döhner H; Ehninger G; Ganser A; Niederwieser DW; Pfirrmann M
    J Clin Oncol; 2012 Oct; 30(29):3604-10. PubMed ID: 22965967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress of studies on genetics of childhood acute leukemia].
    Yue ZX; Zheng HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):791-5. PubMed ID: 23815942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of clinical outcome and analysis of prognosis related factor in children with acute myeloid leukemia].
    Zou Y; Wang H; Chen XJ; Wang SC; Zhang L; Chen YM; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):621-5. PubMed ID: 17278430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
    Gorman MF; Ji L; Ko RH; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
    Pediatr Blood Cancer; 2010 Sep; 55(3):421-9. PubMed ID: 20658611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analyses of karyotypic characteristics and prognosis in pediatric acute myeloblastic leukemia].
    Ruan M; Wang YQ; Zhang L; Zou Y; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):725-8. PubMed ID: 23336225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved survival outcome of childhood acute myeloid leukemia with intensified chemotherapy in Chinese children.
    Zhai XW; Cheng FW; Lee V; Leung WK; Ng MH; Tsang KS; Shing MK; Li CK
    Pediatr Hematol Oncol; 2011 May; 28(4):269-78. PubMed ID: 21345081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG).
    Wedding U; Bokemeyer C; Meran JG; ; ;
    Onkologie; 2004 Feb; 27(1):72-82. PubMed ID: 15007253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress in the treatment of acute leukemia].
    Kimura Y
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease.
    Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V
    Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
    von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
    J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.